These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 8361040

  • 1. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
    Okumura N, Furuwatari C, Ishikawa S, Furihata K, Katsuyama T, Kanai M, Nakahata T, Saitoh H.
    Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
    [Abstract] [Full Text] [Related]

  • 2. [Studies on the fragments of FDP in 4 patients with DIC].
    Okumura N, Furuwatari C, Ishikawa S, Furihata K, Katsuyama T, Kanai M, Nakahata T, Saitoh H.
    Rinsho Byori; 1992 Oct; 40(10):1089-95. PubMed ID: 1307614
    [Abstract] [Full Text] [Related]

  • 3. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N, Furuwatari C, Ishikawa S, Furihata K, Katsuyama T, Kanai M, Nakahata T, Saitoh H.
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [Abstract] [Full Text] [Related]

  • 4. [Studies on the fragments of FDP in 3 non-DIC patients with increased FDP levels in the sera].
    Okumura N, Furuwatari C, Ishikawa S, Furihata K, Katsuyama T, Kanai M, Shinoda T, Nakahata T, Saitoh H.
    Rinsho Byori; 1993 Feb; 41(2):220-6. PubMed ID: 8361025
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N, Kagiya H, Kumagai T, Kameko M, Tozuka M, Saito H, Katsuyama T, Kanai M.
    Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Okajima K, Koga S, Okabe H, Inoue M, Takatsuki K.
    Acta Haematol; 1989 Feb; 81(1):15-8. PubMed ID: 2494830
    [Abstract] [Full Text] [Related]

  • 8. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L.
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [Abstract] [Full Text] [Related]

  • 9. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
    Chuecas F, Loredo E, Muñoz B, Alfaro J, Grebe G, Lira P.
    Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
    [Abstract] [Full Text] [Related]

  • 10. [Hemostatic changes before and after the onset of disseminated intravascular coagulation].
    Wada H, Tanigawa M, Takagi M, Suzuki H, Mori Y, Ohta T, Kobayashi T, Kita K, Tanaka I, Yamaguchi T.
    Rinsho Ketsueki; 1989 Oct; 30(10):1755-62. PubMed ID: 2593241
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
    Takahashi H, Tatewaki W, Wada K, Niwano H, Shibata A.
    Thromb Haemost; 1990 Jun 28; 63(3):340-4. PubMed ID: 2402738
    [Abstract] [Full Text] [Related]

  • 13. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
    Gando S, Hayakawa M, Sawamura A, Hoshino H, Oshiro A, Kubota N, Jesmin S.
    Thromb Res; 2007 Jun 28; 121(1):67-73. PubMed ID: 17397908
    [Abstract] [Full Text] [Related]

  • 14. [Role of PMN elastase in fibrinolytic activity in patients with acute promyelocytic leukemia].
    Soma M, Maeda Y, Kasakura S, Yabe H.
    Rinsho Ketsueki; 1990 Sep 28; 31(9):1445-9. PubMed ID: 2246816
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N, Kuroso K, Fujimaki M, Yorifuji H, Fukutake K.
    Rinsho Byori; 1993 Dec 28; 41(12):1349-52. PubMed ID: 8295346
    [Abstract] [Full Text] [Related]

  • 17. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S.
    Rinsho Byori; 2004 Apr 28; 52(4):355-61. PubMed ID: 15164605
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.